Approval · Notice of Compliance 1856 · 1999
INTRON A: Notice of Compliance 1856
Issued August 13, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1856
- Date
- August 13, 1999
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Three new strengths for solution in multi-dose pen - albumin (human) free
- Therapeutic class
- Biological response modifier
Products in this notice
Medicinal ingredients
- INTERFERON ALFA 2B 15,000,000 UNIT per ML
- INTERFERON ALFA 2B 25,000,000 UNIT per ML
- INTERFERON ALFA 2B 50,000,000 UNIT per ML